Aims and Scope of Journal of Clinical Oncology
The Journal of Clinical Oncology is a peer-reviewed medical journal published 3 times a month by the American Society of Clinical Oncology. It covers research on all aspects of clinical oncology. All articles older than one year are freely available online. The journal was established in 1983 and the editor-in-chief is Jonathan W. Friedberg. JCO's Impact Factor is 32.956 as reported by Clarivate in its 2019 Journal Citation Reports. Less
Key Metrics
CiteScore 

40.9
Eigenfactor 

0.1 - 0.5
Impact Factor 

>= 25
Scite Index 

0.87 5-Year SI

SJR 

Q1Oncology

SNIP 

6.97
Recommended pre-submission checks
Powered by 

Topics Covered on Journal of Clinical Oncology
Journal of Clinical Oncology Journal Specifications
| Overview | |
| Publisher | LIPPINCOTT WILLIAMS & WILKINS |
| Language | English |
| Frequency | Fortnightly |
| General Details | |
| Language | English |
| Frequency | Fortnightly |
| Publication Start Year | 1983 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Journal of Clinical Oncology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Journal of Clinical Oncology
Are You Bereaved?
- 25 Nov 2025
- Journal of Clinical Oncology
Efficacy and Safety of Neoadjuvant TQB2102 in Locally Advanced or Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: A Randomized, Open-Label, Multicenter, Phase II Trial.
- 25 Nov 2025
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Reply to: Optimizing Control Arms in Chronic Lymphocytic Leukemia Clinical Trials: The BRUIN-CLL-321 Trial.
- 21 Nov 2025
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Optimizing Control Arms in Chronic Lymphocytic Leukemia Clinical Trials: The BRUIN-CLL-321 Trial.
- 21 Nov 2025
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Carboplatin for Premenopausal Triple-Negative Breast Cancer: Time to Rethink the Neoadjuvant Standard?
- 21 Nov 2025
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
If Exercise Were a Pill, We'd All Prescribe It to Patients With Cancer. But It's Not.
- 21 Nov 2025
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Are You Bereaved?
- 25 Nov 2025
- Journal of Clinical Oncology
Efficacy and Safety of Neoadjuvant TQB2102 in Locally Advanced or Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: A Randomized, Open-Label, Multicenter, Phase II Trial.
- 25 Nov 2025
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Reply to: Optimizing Control Arms in Chronic Lymphocytic Leukemia Clinical Trials: The BRUIN-CLL-321 Trial.
- 21 Nov 2025
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Optimizing Control Arms in Chronic Lymphocytic Leukemia Clinical Trials: The BRUIN-CLL-321 Trial.
- 21 Nov 2025
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Carboplatin for Premenopausal Triple-Negative Breast Cancer: Time to Rethink the Neoadjuvant Standard?
- 21 Nov 2025
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
If Exercise Were a Pill, We'd All Prescribe It to Patients With Cancer. But It's Not.
- 21 Nov 2025
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology